Patent · US Active

Acyclic IKur inhibitors

US8357809B2 · kind B2 · utility

2Cited by

16References

2Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

James A. Johnson · Lawrenceville, US
Yoon Jeon · Montgomery, US
John Lloyd · Yardley, US
Heather Finlay · Skillman, US

Key dates

Filing date	Mar 15, 2011
Grant date	Jan 22, 2013
Priority date	—
Expiry date	Mar 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula Iwherein R1, R2, R3, R4 and R5 are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.